Could a 66-cent pill replace CPAP for sleep apnea?
NCT ID NCT05616260
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether acetazolamide, a cheap and well-tolerated water pill, can reduce sleep apnea severity and lower blood pressure in young adults (18–50 years old) who cannot or will not use a CPAP mask. 54 participants received either the drug or a placebo for two weeks each. The goal is to offer a simple, once-daily pill option for the millions of OSA patients who struggle with current treatments.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBSTRUCTIVE SLEEP APNEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UC San Diego; Altman Clinical and Translational Research Institute Building
La Jolla, California, 92121, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Do current sleepiness tests work for kids? a new study puts them to the test
- Remote monitoring may boost sleep apnea therapy adherence
- Could a mouthpiece replace the CPAP machine for sleep apnea?
- Can a new painkiller prevent breathing crises after surgery?
- Personalizing sleep apnea treatment: a step toward better CPAP outcomes
- A blood test for sleep apnea? MicroRNAs may hold the key